Clinical Trial Update: Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating anticoagulation strategies (unfractionated heparin, argatroban, and low molecular weight heparin) for ECMO support; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• Circulatory Failure
• Respiratory Failure
• Thromboembolism

Drugs mentioned

• Argatroban (argatroban)
• Low molecular weight heparin (low molecular weight heparin)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Respiratory Insufficiency, Circulatory Failure | Phase 4 | Status: RECRUITING